Nabriva Therapeutics PLC (NBRVF)

[skitahoe]

Dilution is a fact, whether at a higher, or lower share price, as long as a company is developing products, and not generating substantial earnings. I'm not that adverse to it when it's needed to maintain operation and not be starved financially. I don't want the R/S, I believe if it fails the price will exceed $1, and then they will probably dilute. As long as they stay above $1 for 10 days, they're qualified to stay on the Nasdaq another year, while I'd hope they didn't dilute to the point of taking it below $1, if they do they'll have time to build it back up.

Gary